BDBM425969 5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)-butoxy)-chroman-4-one::US10513512, Compound P2

SMILES COc1ccccc1N1CCN(CCCCOc2cc(O)c3C(=O)CC(Oc3c2)c2ccc(C)cc2)CC1

InChI Key InChIKey=QQIXFSRRLUIGLM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 425969   

TargetD(2) dopamine receptor(Human)
Xuanwu Hospital of Capital Medical University

US Patent
LigandPNGBDBM425969(5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(2-methoxyph...)
Affinity DataIC50: 346nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent